Table 1 Patients’ characteristics
From: Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Cohort | n = 34 |
|---|---|
Age (years) | |
Median (range) | 61 (22–76) |
Gender—n (%) | |
Female | 14 (41.2) |
Male | 20 (58.8) |
Karnofsky performance score at diagnosis | |
Median | 90 |
Extent of primary resection—n (%) | |
Complete | 17 (50.0) |
Partial | 6 (17.6) |
Open biopsy | 11 (32.4) |
IDH-mutation status—n (%) | |
Wildtype | 33 (97.1) |
Mutated | 1 (2.9) |
MGMT promoter status—n (%) | |
Methylated | 11 (32.4) |
Non-methylated | 6 (17.6) |
Not determined | 17 (50.0) |
Progression-free survival | |
Median (months) | 22.4 |
Overall survival | |
Median (months) | 35.8 |